T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
JPMorgan Chase
JPM
|
+$1.7B |
| 2 |
Verizon
VZ
|
+$1.36B |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 4 |
US Bancorp
USB
|
+$1.29B |
| 5 |
Merck
MRK
|
+$1.23B |
Top Sells
| 1 |
Amazon
AMZN
|
+$5.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$4.57B |
| 3 |
Tesla
TSLA
|
+$3.67B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.43B |
Sector Composition
| 1 | Technology | 26.72% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.69% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Cogent Biosciences
COGT
$1.79B
| $129K | ﹤0.01% |
11,122
+1,018
| +10% | +$11.8K |
|
|
NKLA
2652
DELISTED
Nikola Corporation Common Stock
NKLA
| $129K | ﹤0.01% |
1,985
+404
| +26% | +$26.3K |
|
|
TWKS
2653
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $129K | ﹤0.01% |
12,645
+848
| +7% | +$8.65K |
|
|
GRTS
2654
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $129K | ﹤0.01% |
37,300
| – | – |
|
2655
Organogenesis Holdings
ORGO
$637M
| $128K | ﹤0.01% |
47,475
+15,602
| +49% | +$42.1K |
|
2656
Telos
TLS
$502M
| $128K | ﹤0.01% |
25,214
+7,684
| +44% | +$39K |
|
2657
NN Inc
NNBR
$118M
| $127K | ﹤0.01% |
84,920
+17,600
| +26% | +$26.3K |
|
2658
ARKO Corp
ARKO
$578M
| $126K | ﹤0.01% |
14,595
+1,364
| +10% | +$11.8K |
|
|
TAST
2659
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $126K | ﹤0.01% |
92,390
-18,500
| -17% | -$25.2K |
|
|
BFX
2660
DELISTED
BowFlex Inc.
BFX
| $126K | ﹤0.01% |
82,600
| – | – |
|
|
EFC
2661
Ellington Financial
EFC
$1.36B
| $125K | ﹤0.01% |
+10,080
| New | +$125K |
|
2662
eHealth
EHTH
$125M
| $124K | ﹤0.01% |
25,580
+676
| +3% | +$3.28K |
|
2663
MiMedx Group
MDXG
$1.04B
| $124K | ﹤0.01% |
44,763
+12,722
| +40% | +$35.2K |
|
2664
Repay Holdings
RPAY
$504M
| $124K | ﹤0.01% |
15,348
+1,803
| +13% | +$14.6K |
|
2665
ADMA Biologics
ADMA
$3.88B
| $123K | ﹤0.01% |
31,829
+2,986
| +10% | +$11.5K |
|
|
CHMI
2666
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $123K | ﹤0.01% |
21,176
+1,200
| +6% | +$6.97K |
|
2667
Rush Street Interactive
RSI
$2.04B
| $123K | ﹤0.01% |
34,395
+615
| +2% | +$2.2K |
|
2668
Heron Therapeutics
HRTX
$195M
| $121K | ﹤0.01% |
48,237
+2,118
| +5% | +$5.31K |
|
2669
Natural Gas Services Group
NGS
$334M
| $121K | ﹤0.01% |
10,588
-3,300
| -24% | -$37.7K |
|
2670
Kodak
KODK
$482M
| $120K | ﹤0.01% |
39,277
+828
| +2% | +$2.53K |
|
2671
ClearPoint Neuro
CLPT
$323M
| $119K | ﹤0.01% |
+14,000
| New | +$119K |
|
2672
Marine Products Corp
MPX
$323M
| $118K | ﹤0.01% |
+10,022
| New | +$118K |
|
2673
Ocular Therapeutix
OCUL
$2.24B
| $118K | ﹤0.01% |
41,861
+10,972
| +36% | +$30.9K |
|
2674
GoodRx Holdings
GDRX
$1.46B
| $117K | ﹤0.01% |
25,100
| – | – |
|
|
VRAY
2675
DELISTED
ViewRay, Inc.
VRAY
| $117K | ﹤0.01% |
26,033
+2,919
| +13% | +$13.1K |
|